Withuspharmaceutical Financials
| 330350 Stock | KRW 6,740 40.00 0.60% |
Withuspharmaceutical |
Understanding current and past Withuspharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Withuspharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Withuspharmaceutical's assets may result in an increase in income on the income statement.
Please note, the presentation of Withuspharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Withuspharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Withuspharmaceutical's management manipulating its earnings.
Withuspharmaceutical Stock Summary
Withuspharmaceutical competes with Kolon Life, JETEMA, Aminologics CoLtd, Daihan Pharmaceutical, and HLB Pharmaceutical. Withus Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea. The company was founded in 2005 and is headquartered in Seoul, South Korea. Withus Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| Business Address | Withus Building, Seoul, |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Benchmark | Dow Jones Industrial |
| Website | www.withuspharm.com |
| Phone | 82 2 3486 7474 |
| Currency | KRW - South Korean Won |
You should never invest in Withuspharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Withuspharmaceutical Stock, because this is throwing your money away. Analyzing the key information contained in Withuspharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Withuspharmaceutical Key Financial Ratios
Withuspharmaceutical's financial ratios allow both analysts and investors to convert raw data from Withuspharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Withuspharmaceutical over time and compare it to other companies across industries.Withuspharmaceutical Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Withuspharmaceutical's current stock value. Our valuation model uses many indicators to compare Withuspharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Withuspharmaceutical competition to find correlations between indicators driving Withuspharmaceutical's intrinsic value. More Info.Withuspharmaceutical CoLtd is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.01 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Withuspharmaceutical CoLtd is roughly 99.65 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Withuspharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Withuspharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Withuspharmaceutical Systematic Risk
Withuspharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Withuspharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Withuspharmaceutical correlated with the market. If Beta is less than 0 Withuspharmaceutical generally moves in the opposite direction as compared to the market. If Withuspharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Withuspharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Withuspharmaceutical is generally in the same direction as the market. If Beta > 1 Withuspharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Withuspharmaceutical November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Withuspharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Withuspharmaceutical CoLtd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Withuspharmaceutical CoLtd based on widely used predictive technical indicators. In general, we focus on analyzing Withuspharmaceutical Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Withuspharmaceutical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 9.83 | |||
| Value At Risk | (3.93) | |||
| Potential Upside | 3.1 |
Complementary Tools for Withuspharmaceutical Stock analysis
When running Withuspharmaceutical's price analysis, check to measure Withuspharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Withuspharmaceutical is operating at the current time. Most of Withuspharmaceutical's value examination focuses on studying past and present price action to predict the probability of Withuspharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Withuspharmaceutical's price. Additionally, you may evaluate how the addition of Withuspharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |